News
Immunetune Strengthens Team by Appointing Sijme Zeilemaker as Chief Executive Officer
Immunetune Strengthens Team by Appointing Sijme Zeilemaker as Chief Executive Officer LEIDEN, the Netherlands, August 11, 2021 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced...
Neoantigen Summit Europe, 20 – 22 April 2021
Our CEO, Gerben Zondag will present Immunetune's unique platform AmpliVax that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming digital Neoantigen Summit Europe on 20-22 Apri...
Bio-Europe Spring, 22-25 March 2021
We will attend the digital Bio-Europe Spring patnering meeting on 22 – 25 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.
Immunetune Strengthens Team by Appointing Sijme Zeilemaker as Chief Executive Officer
Immunetune Strengthens Team by Appointing Sijme Zeilemaker as Chief Executive Officer LEIDEN, the Netherlands, August 11, 2021 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases, today announced...
Neoantigen Summit Europe, 20 – 22 April 2021
Our CEO, Gerben Zondag will present Immunetune's unique platform AmpliVax that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming digital Neoantigen Summit Europe on 20-22 Apri...
Bio-Europe Spring, 22-25 March 2021
We will attend the digital Bio-Europe Spring patnering meeting on 22 – 25 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.
Sachs Associates EU Life Sciences CEO Forum, 10 -11 March 2021
We will attend the digital Sachs Associates 14th European Life Sciences CEO Forum on 10-11 March 2021. Feel free to request a meeting if you’d like to hear more about possible partnering or investment opportunities.